Csl Ltd has released a press release.
Update on CSL Agreement with uniQure
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from CSL
- Statutory Accounts for the Half Year Ended 31 Dec 2020
- Dividend/Distribution - CSL
- Update on UQ-CSL v451 COVID-19 Vaccine
- Chairmans Address to Shareholders
- CSL Supply Agreement for UQ Vaccine with Commonwealth
Later from CSL
- CSL Statutory Accounts for the Full Year Ended 30 June 2021
- Trading Halt
- Swiss tender offer to acquire 100% of vifor pharma ltd
- Investor Presentation CSL Swiss Tender Acquisition of Vifor
- Successful Completion of A$6.3B Institutional Placement
Follow CSL into a list and get an email when it puts out news.
Follow CSL